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Abstract
Background: Three non-synonymous single nucleotide polymorphisms (Q223R, K109R and K656N) of the leptin receptor
gene (LEPR) have been tested for association with obesity-related outcomes in multiple studies, showing inconclusive
results. We performed a systematic review and meta-analysis on the association of the three LEPR variants with BMI. In
addition, we analysed 15 SNPs within the LEPR gene in the CoLaus study, assessing the interaction of the variants with sex.
Methodology/Principal Findings: We searched electronic databases, including population-based studies that investigated
the association between LEPR variants Q223R, K109R and K656N and obesity- related phenotypes in healthy, unrelated
subjects. We furthermore performed meta-analyses of the genotype and allele frequencies in case-control studies. Results
were stratified by SNP and by potential effect modifiers. CoLaus data were analysed by logistic and linear regressions and
tested for interaction with sex. The meta-analysis of published data did not show an overall association between any of the
tested LEPR variants and overweight. However, the choice of a BMI cut-off value to distinguish cases from controls was
crucial to explain heterogeneity in Q223R. Differences in allele frequencies across ethnic groups are compatible with natural
selection of derived alleles in Q223R and K109R and of the ancient allele in K656N in Asians. In CoLaus, the rs10128072,
rs3790438 and rs3790437 variants showed interaction with sex for their association with overweight, waist circumference
and fat mass in linear regressions.
Conclusions: Our systematic review and analysis of primary data from the CoLaus study did not show an overall association
between LEPR SNPs and overweight. Most studies were underpowered to detect small effect sizes. A potential effect
modification by sex, population stratification, as well as the role of natural selection should be addressed in future genetic
association studies.
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Introduction
In the past few decades, the prevalence and incidence of obesity
has rapidly increased globally and has reached epidemic propor-
tions [1,2]. Obesity is associated with many deleterious outcomes
such as type 2 diabetes, hypercholesterolemia, hypertension or heart
disease, and is directly related to increased mortality and reduced
life expectancy [2]. With the completion of the human genome
project and the first extensive genome-wide association studies,
increasing numbers of risk alleles associated with obesity have been
identified [3–5], some of them in genes not previously known to be
associated with adiposity. However, to date, genome-wide associ-
ation studies have only captured a small percentage of the genetic
variance related to obesity or body mass index [6].
One commonly studied candidate gene for obesity, the leptin
receptor gene (LEPR), is on a biologic pathway to obesity (leptin-
insulin pathway) [7]. Leptin is produced in adipose tissue and in
other organs. It is known to have pleiotropic actions, including
regulation of several neuropeptides involved in appetite control [8]
and thermogenesis [9]. Three non-synonymous single nucleotide
polymorphisms of the LEPR gene (Q223R, K109R and K656N)
have been tested for association with obesity-related outcomes in
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multiple studies, producing inconclusive results [e.g. 10,11,12,13].
Two systematic reviews on these variants did not show an overall
statistically significant association to obesity-related outcomes
[14,15]. However, many further studies on the association
between LEPR variants and obesity have been published since
the last review in 2005 [15], including studies on the interaction of
these variants with sex or with other factors [e.g. 16]. We therefore
performed a systematic review and meta-analysis on the
association between the three LEPR variants Q223R, K109R
and K656N and obesity-related outcomes.
As most studies do not report data stratified by sex or other
possible effect modifiers, we additionally analysed 38 SNPs within
the LEPR gene (among them K109R) in a cohort of more than
6000 Caucasian adults from the Swiss CoLaus study [17], (data
unpublished to date). We assessed the association of the SNPs with
a number of different obesity-related outcomes and for possible
confounding variables, or interaction with sex. This approach
allowed us to account for the need for more precise phenotyping of
study subjects [18]. Furthermore, the issue of sample size in
association studies is crucial [6]. Our approach provides data on a
cohort with a larger sample size than the ones assessed in the
systematic review.
Materials and Methods
Systematic review
We followed the guidelines PRISMA for the reporting of
systematic reviews and meta-analyses [19]. The electronic
databases Medline, Embase and ISI Web of Knowledge were
searched (search date: 14 October 2009). The search strategy was
carried out for all exposures and outcomes of interest. Search
terms included LEPR, leptin receptor gene, Q223R, K109R,
K656N, obesity, body mass index, BMI, weight, waist, waist-to-hip
ratio, WHR, body fat, adiposity, overweight, fat mass, Quetelet
index. Where possible, MeSH headings (or other standardized
indexing terms) were used. The search was restricted to humans,
but unrestricted for publication date or language (see supporting
Table S1 for Medline search strategy. The search strategies for
Embase and ISI were similar). We restricted the review to healthy
people in order to separate potential associations of the SNPs with
diabetes II, hypertension or with other diseases and only assess
potential associations with overweight. This strategy was also
followed by the previous review on the same topic by Paracchini
and colleagues [15]. The reference lists of all included studies were
examined to identify studies not found by the electronic databases
search. The retrieved references were checked by title and abstract
for inclusion or exclusion, according to the following criteria.
Inclusion criteria: exposure: at least one of the LEPR SNPs
Q223R, K109R or K656N; outcome: BMI, body fat percentage,
weight, waist circumference, hip circumference, waist-to-hip ratio
or other weight-related outcome; non related subjects, either sex,
any ethnic group, any BMIs and all population based study
designs. Exclusion criteria: studies not meeting the inclusion
criteria; furthermore, studies including only non-healthy subjects
(both study arms with e.g. diabetes, cancer or hypertension
patients) and family-based studies. All included studies were
retrieved as full text and reviewed again for inclusion and
exclusion. The inclusion and exclusion process was performed at
each level according to pre-established criteria by two independent
reviewers (NB and NA), and consensus was reached by discussion.
Data was extracted from all the studies included as full text
papers by the two independent reviewers on a standard data
extraction sheet and entered into an electronic database (EpiData
3.1). Consensus was reached by discussion. Data extracted
included reference details (author, year, journal), study design
(case-control, cohort, comparative study), details of the population
(sex, ethnicity, setting), sample size per comparison group, SNP
studied, allele and genotype frequency per comparison group,
obesity-related phenotypes tested (e.g. BMI, waist circumference),
strength of association (odds ratios and confidence intervals), and
potential confounders accounted for. If necessary data was not
reported in the primary manuscript, the corresponding authors
were contacted by email to request the missing data. Quality
criteria were developed to assess the internal validity of the studies
and the accuracy of reporting, using the guidelines for the
assessment of cumulative evidence on genetic associations [20], the
HuGe Review Handbook [21] and the extension of the STROBE
statement STREGA (strengthening the reporting of genetic
association studies) [22]. The quality of data was considered in
the final interpretation of the findings.
Data analysis and meta-analysis
Data was analysed descriptively and statistically for each LEPR
gene variant separately and stratified by ethnic group. Ethnic
groups were defined according to Rosenberg et al [23]. For the
analysis of association between LEPR variants and overweight,
case-control studies, (where cases are obese people without other
known disease and controls are healthy non-obese people), were
included. For genotype and allele frequencies, single group studies,
(consisting of cohorts, cross-sectional studies or healthy control
arms of case-control studies), were also analysed. Reported
statistical analyses on the association between a SNP and an
obesity-related outcome that did not present results in a format
convenient for a meta-analysis, (such as linear regression,
ANOVA, and non-parametric analyses), were extracted and taken
into account in the interpretation of the findings.
Derived allele frequencies of each SNP were summarized in
Tables, stratified by ethnic group (including CoLaus data, see
below). If a study reported data separately for subgroups (such as
sex, country or cohort of origin), the subgroups were included in
the analysis of genotype and allele frequencies. The heterogeneity
between allele frequencies in different ethnic groups was assessed
using Cochran’s Q statistic. In case-control studies, associations
between genotype, allele data and obesity were assessed by chi-
square tests, general linear models and meta-analyses, according to
different inheritance models (co-dominant, dominant and reces-
sive), given the a priori absence of evidence on the allelic mode of
action. If odds ratios and/or confidence intervals were missing,
these were calculated. We used 0.006 (0.05/9, because three
models were tested for 3 SNPs) as the cut-off p-value to declare an
association as significant in case-control studies (Tables 1–3).
For the meta-analyses, data was pooled using a random effects
model, to calculate summary odds ratios with 95% confidence
intervals, by SNP. The statistical evidence for heterogeneity
between studies was assessed by I2 statistics [24]. Funnel plots of
study precision were used to examine a possible small study bias,
using Begg and Egger statistics [25].
CoLaus data
The CoLaus study (Cohorte Lausannoise) is a population-based
study including 6’184 Caucasian adults aged 35–75 years from the
city of Lausanne, Switzerland [17]. The study population consisted
of 52.5% women. The mean age was 51.1 years (standard deviation
of 610.9). The following obesity-related phenotypic measurements
were performed by trained nurses: body weight, body height, body
fat percentage (by electrical bioimpedance using the BodystatH 1500
analyzer [Isle of Man, British Isles]), waist and hip circumferences.
Body weight and height were measured with participants standing
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without shoes in light indoor clothing. Body weight was measured in
kilograms to the nearest 0.1 kg using a SecaH Scale (Hamburg,
Germany), which was calibrated regularly. Height was measured to
the nearest 5 mm using a SecaH height gauge (Hamburg,
Germany). Waist circumference was measured twice with a
nonstretchable tape over the unclothed abdomen at the mid-point
between the lowest rib and the iliac crest. The mean of the two
measurements was used for analyses. Furthermore, a number of
additional potential confounders and effect modifiers were assessed
by questionnaire or interview, including geographic origins [26],
smoking status, alcohol consumption and menopausal status.
Genotyping was performed using the Affymetrix 500K chip, 38
Table 1. Analysis of genotypes for Q223R in case-control studies, according to different allelic modes of action.
Reference
Co-dominant: OR
(95% CI)*
Co-dominant:
p-value*
Dominant: OR
(95% CI)**
Dominant:
Chi2 (p-value)**
Recessive: OR
(95% CI)**
Recessive: Chi2
(p-value)**
Caucasians
Chagnon 1999 [61] 0.89 (0.74–1.07) 0.221 0.87 (0.52–1.45) 0.34 (0.557) 0.66 (0.36–1.19) 2.19 (0.139)
Yiannakouris 2001 [10] 1.45 (0.75–2.80) 0.263 0.96 (0.38–2.44) 0.01 (0.924) 5.54 (1.13–27.27) 7.40 (0.007)
Mattevi 2002 [31] 1.62 (1.15–2.26) 0.005 1.60 (0.99–2.59) 4.05 (0.044) 2.44 (1.16–5.12) 6.92 (0.009)
Portole´s 2006 [62] 0.84 (0.68–1.04) 0104 0.88 (0.65–1.18) 0.84 (0.360) 0.62 (0.38–1.03) 3.96 (0.047)
De Krom 2007 [63] 1.00 (0.73–1.37) 0.991 0.77 (0.45–1.30) 1.11 (0.293) 1.33 (0.76–2.30) 1.14 (0.285)
Mergen 2007 [32] 1.43 (1.03–1.99) 0.034 1.65 (1.06–2.56) 5.45 (0.020) 1.31 (0.60–2.83) 0.55 (0.457)
Bienertova 2008 [64] 0.88 (0.57–1.36) 0.564 1.06 (0.50–2.23) 0.03 (0.872) 0.65 (0.30–1.44) 1.33 (0.248)
Masuo 2008 [16] 1.87 (1.10–3.16) 0.021 2.10 (0.90–4.90) 3.55 (0.060) 2.89 (0.88–9.49) 4.22 (0.040)
Overall I2 = 69.8% I2 p = 0.002 1.13 (0.87–1.45) 0.368 I2 = 66.5% I2 p = 0.004
Asians
Endo 2000 [65] 0.89 (0.58–1.37) 0.604 1.27 (0.20–8.25) 0.10 (0.754) 0.84 (0.49–1.42) 0.51 (0.475)
Wang 2006 [30] 1.32 (0.7–2.38) 0.347 1.51 (0.75–3.04) 1.57 (0.210) 0.39 (0.01–13.37) 0.61 (0.433)
Overall 1.02 (0.71–1.47) 0.924 1.48 (0.77–2.85) 0.244 0.82 (0.49–1.38) 0.459
Mixed populations
Guı´zar-mendoza 2005 [66] 0.70 (0.36–1.34) 0.278 0.78 (0.33–1.84) 0.40 (0.527) 0.33 (0.04–2.74) 1.86 (0.173)
Duarte 2007 [67] 1.24 (0.89–1.71) 0.202 1.65 (1.02–2.68) 4.69 (0.030) 0.86 (0.45–1.65) 0.24 (0.628)
Overall 1.00 (0.58–1.72) 0.991 1.24 (0.60–2.54) 0.564 0.79 (0.43–1.48) 0.465
Overall all populations I2 = 56.7% I2 p = 0.006 1.15 (0.93–1.43) 0.185 I2 = 52.0% I2 p = 0.018
Odds ratios and 95% confidence intervals are given. Statistically significant results are shown in bold. Where the overall measure was significantly heterogeneous, the I2
value and its p-value are given instead of the overall measure.
*Values from generalized linear model, overall results from meta-analysis, random model.
**Values from meta-analysis, random model.
doi:10.1371/journal.pone.0026157.t001
Table 2. Analysis of genotypes for K109R in case-control studies, according to different allelic modes of action.
Reference
Co-dominant: OR
(95% CI)*
Co-dominant:
p-value*
Dominant: OR
(95% CI)**
Dominant: Chi2
(p-value)**
Recessive: OR
(95% CI)**
Recessive: Chi2
(p-value)**
Caucasians
Chagnon 1999 [61] 0.82 (0.58–1.16) 0.253 0.94 (0.59–1.51) 0.07 (0.797) 0.38 (0.14–1.04) 4.70 (0.030)
Yiannakouris 2001 [10] 1.49 (0.62–3.61) 0.376 1.31 (0.45–3.83) 0.32 (0.574) Not calculable 3.10 (0.079)
De Krom 2007 [63] 1.13 (0.78–1.62) 0.520 1.30 (0.77–2.18) 1.10 (0.294) 0.87 (0.34–2.23) 0.11 (0.739)
Masuo 2008 [16] 0.74 (0.37–1.48) 0.391 0.81 (0.34–1.93) 0.28 (0.599) 0.22 (0.01–7.46) 1.83 (0.177)
CoLaus men 0.91 (0.77–1.08) 0.298 0.91 (0.73–1.14) 0.67 (0.413) 0.81 (0.51–1.27) 0.95 (0.329)
CoLaus women 1.01 (0.86–1.18) 0.918 1.01 (0.82–1.23) 0.00 (0.959) 1.04 (0.67–1.60) 0.03 (0.872)
Overall 0.96 (0.87–1.07) 0.449 0.98 (0.86–1.12) 0.782 0.84 (0.63–1.12) 0.242
Asians
Qu 2007 [68] 1.04 (0.77–1.41) 0.800 0.97 (0.34–2.76) 0.00 (0.950) 1.06 (0.73–1.53) 0.10 (0.750)
Overall all populations 0.97 (0.88–1.07) 0.526 0.98 (0.86–1.12) 0.779 0.90 (0.72–1.13) 0.372
Odds ratios and 95% confidence intervals are given. Statistically significant results are shown in bold.
*Values from generalized linear model, overall results from meta-analysis, random model.
**Values from meta-analysis, random model.
doi:10.1371/journal.pone.0026157.t002
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SNPs were located within the LEPR gene. In order to reduce the
number of statistical tests performed, we chose 15 SNPs that tagged
[27] all 38 SNPs (see complete list of covered SNPs on supporting
Table S2), using the Haploview programme [28]. The 15 selected
genotyped SNPs available at the LEPR locus tag 13, 26 and 33 SNPs
from HapMap CEU release 22 using r2.0.8, .0.7 and .0.6,
respectively, out of 208 SNPs (among which 188 SNPs have MAF
.5%) available in this region. These tagging SNPs cover the entire
gene region, including the 39 UTR. We therefore consider that the
set of SNPs we analyzed covers moderately well this locus. Relevant
data on 5636 people was available for analysis in the present paper.
Missing data was mostly due to missing genotype data.
We used logistic regressions to test the association of 15 tag
LEPR SNPs (among them K109R) with the dichotomized body
mass index (BMI) or waist circumference. Cut-off value for BMI
was 25; cut-off value for waist circumference was 88 cm in women
and 102 cm in men [29]. In addition, we performed linear
regressions on body mass index, waist circumference, fat mass and
leptin levels as continuous variables. Leptin level data was
subjected to natural logarithmic transformation in order to better
achieve normality of the residuals and homoscedasticity. We
reported associations corrected for potential confounders like sex,
age, height (for outcomes other than body mass index), alcohol
consumption, smoking and geographic variation (expressed as
principal components pc1 and pc2 from principal component
analyses). These covariables showed an association with over-
weight-related phenotypes and with some of the SNPs studied in
univariate regression analyses. We also assessed a potential
interaction with sex. For analyses on the CoLaus data, we used
0.0033 (0.05/15) as the cut-off p-value to declare an association as
significant. For interaction tests, we used 0.05 as the cut-off p-value
to declare an interaction as significant. In the CoLaus analyses, we
had more than 80% power to detect an additive association
explaining 0.3% of trait variance for single SNP analysis and 80%
power to detect an interaction explaining 0.14% of the variance.
All statistical analyses were conducted using STATA statistical
package v 9.0 (Stata corp, College Station, TX, USA).
Results
Systematic review
In total, 1630 papers were found through the search in
electronic databases or by manual search. Fifty-five studies
satisfied the inclusion and exclusion criteria and were obtainable
as full text papers. Seventeen were case-control studies comparing
obese with non-obese people and could be used for the meta-
analyses. Thirty-eight studies were categorized as single group
studies and contained data on genotype and allele frequencies (see
the flow chart in Figure 1). supporting Table S3 presents
participants’ characteristics for case- control studies and support-
ing Table S4 for single group studies.
Thirty studies were carried out on Caucasians, sixteen studies
were carried out on Asians, four on people of African ancestry and
six on populations of mixed ancestry, such as Brazilians or
Mexicans. Most studies reported BMI as outcome, many studies
reported several obesity-related outcomes, like body weight, body
fat mass or waist-to-hip ratio. Most studies were carried out with
participants of both sexes and with adults. Q223R was the most
commonly studied SNP (52 studies), followed by K109R (20
studies) and K656N (20 studies).
Study quality
Overall, studies reported well on the participants’ characteristics
(summarized in supporting Tables S3 and S4) and on genotyping
and analysis methods. Most studies did not report on missing data,
and several call rates (the percentage of successfully genotyped
individuals in the study population) were under 95%. Inclusion
and exclusion criteria, as well as outcome assessments, were not
always well described. Hardy-Weinberg equilibrium was mostly
(but not always) reported as calculated. Genotypes were mostly in
Hardy-Weinberg equilibrium. Potential confounders like sex and
age were assessed in more than half of the studies. Surprisingly, the
calculation or justification of the sample size was rarely described.
The quality of study reporting is therefore of concern for the
interpretation of the results. We assessed effects of small study bias
by funnel plots (see Figure 2). There was no statistical evidence for
publication bias or small study bias.
Genotype and allele frequencies
In this systematic review, A denotes the ancestral allele and D the
derived allele (the derived alleles are 223R, 109R and 656N
respectively). Reported genotype and reported or calculated allele D
frequencies with according 95% confidence intervals of all included
studies are reported in Figure 3 and supporting Tables S5, S6, S7,
by SNP. For each ethnic group the Cochran’s Q statistic and p-
value are given to estimate heterogeneity in allele frequencies across
Table 3. Analysis of genotypes for K656N in case-control studies, according to different allelic modes of action.
Reference
Co-dominant: OR
(95% CI)*
Co-dominant:
p-value*
Dominant: OR
(95% CI)**
Dominant: Chi2
(p-value)**
Recessive: OR
(95% CI)**
Recessive: Chi2
(p-value)**
Caucasians
Chagnon 1999 [61] 1.03 (0.72–1.48) 0.879 1.08 (0.66–1.77) 010 (0.752) 0.90 (0.33–2.46) 0.05 (0.820)
Yiannakouris 2001 [10] 1.15 (0.60–2.24) 0.670 1.25 (0.49–3.19) 0.27 (0.600) 1.03 (0.13–8.22) 0.00 (0.977)
Masuo 2008 [16] 1.71 (0.99–2.97) 0.055 1.97 (0.86–4.50) 3.12 (0.077) 2.28 (0.60–8.72) 2.04 (0.153)
Overall 1.21 (0.89–1.63) 0.226 1.26 (0.86–1.86) 0.238 1.23 (0.58–2.59) 0.596
Asians
Qu 2007 [68] 0.87 (0.52–1.46) 0.587 0.91 (0.51–1.62) 0.12 (0.731) Not calculable 1.42 (0.234)
Overall all populations 1.12 (0.86–1.45) 0.407 1.14 (0.83–1.57) 0.421
Odds ratios and 95% confidence intervals are given. Statistically significant results are shown in bold.
*Results are from generalized linear model, overall results from meta-analysis, random model.
**Results are from meta-analysis, random model.
doi:10.1371/journal.pone.0026157.t003
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studies. Allele frequencies differ strongly between Caucasians and
Asians, with Asians showing much higher derived allele frequencies
for 223R (80.56–95.00% compared to 30.18–56.67% in Cauca-
sians) and 109R (76.47–84.44 compared to 12.29–35.25 in
Caucasians). The Taiwanese aborigines [30] have lower allele
frequency (6.07%) for 223R, than the other Asian populations.
Asians have lower 656N allele frequencies than Caucasians (0.00–
13.97 vs. 14.75–37.98, respectively).
Figure 1. Flow diagram of studies included and excluded in the systematic review. Numbers are given at each exclusion step.
doi:10.1371/journal.pone.0026157.g001
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Figure 2. Begg’s funnel plots of study precision. For included studies on the association between Q223R, K109R and K656N and overweight,
Begg’s funnel plots were used to examine a possible small study bias. The natural logarithm of the odds ratio (OR) vs. its standard error and pseudo
95% confidence intervals are shown, together with Begg and Egger statistics.
doi:10.1371/journal.pone.0026157.g002
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In Caucasians, allele frequencies are heterogeneous in all SNPs
considered. For Q223R, there seems to be a north-south gradient
in Caucasians, with the highest derived frequencies occurring in
north Europe and the lowest derived frequencies found in
Mediterranean countries.
Meta-analyses and further results
Odds ratios of allele frequencies of case-control studies were
analyzed by random effects meta-analyses. Results by SNPs are
shown in Figures 4a–4c. No meta-analysis showed overall
significant results (overall OR for Q223R: 1.05 (95% CI 0.92–
1.21), for K109R: 0.97 (0.88–1.07), for K656N: 1.14 (0.93–1.39)).
Pooled results from meta-analyses of genotypes showed no
significant results in any SNP for any of the three inheritance
models (see Tables 1–3).
The meta-analysis of allele frequencies in Q223R showed
significant heterogeneity (I2 = 43.5%, p= 0.032). Subgroup anal-
yses of Q223R stratifying by ethnicity did not explain this
heterogeneity and did not change any result to a significant
association (Caucasians: OR 1.08 (0.90–1.29), Asians: OR 1.06
(0.76–1.49), mixed populations: OR 0.91 (0.59–1.39)), (see
Figure 4a). The same is true for stratification by type of study
population (see Figure 5a). However, if the meta-analysis of
Q223R was stratified by BMI cutoff value, the heterogeneity
became non-significant in each group (see Figure 5b). The overall
OR for studies with a BMI cutoff value of 25 was significant with
1.30 (1.04–1.63). In studies using higher or unclear cutoff values
the OR showed an opposite trend of 0.94 (0.83–1.07). Meta-
analyses in K109R and K656N did not provide evidence for
overall heterogeneity.
From the single studies on Q223R, only three studies showed an
association between Q223R and obesity [16,31,32], reporting an
increased risk of overweight for the derived allele (OR 2.1 (1.12–3.61),
1.53 (1.11–2.11), and 1.38 (1.00–1.90) respectively). One study
reported data on the association between Q223R alleles and waist
circumference stratified by sex [31]: in men the OR was 2.1 (1.16–
3.47), showing an increased risk of large waist circumference for the
derived allele. In women the OR was 1.15 (0.74–1.79). In our meta-
analysis of genotypes in case-control studies there was only one single
statistically significant result for Q223R genotypes with overweight in
the co-dominant model (OR 1.62 (1.15–2.26) [31]). In the reported
results from ANOVAs or linear regressions for Q223R, eight studies
reported an increased risk of overweight for the derived allele, five a
protective effect and 18 studies did not show an association.
For K109R, one study reported an association with overweight
in women (p = 0.011) [33]. From ANOVAs or linear regressions,
one study reported an increased risk for the derived allele, while
nine studies did not show significant results.
In the results from ANOVAs or linear regressions for K656N,
four studies reported an increased risk of the derived allele, while
five studies did not show significant results.
CoLaus data
Tables 4–5 show the results of the logistic regression analyses of
15 tag SNPs of the LEPR gene in CoLaus. For the association with
overweight, only SNP rs9436746 showed an increased risk for the
minor allele in the additive model (OR 1.13 (1.04–1.23)). No SNP
showed an association with waist circumference and no SNP
showed an interaction with sex. In the linear regressions (supporting
Table S8), SNP rs10889553 showed an association with waist
circumference in the additive model (beta 1.65 (SE 0.51), t-value
3.12, p= 0.001). In linear regressions three SNPs showed an
interaction with sex (rs10128072, rs3790438 and rs3790437 (tag of
K656N)) for the outcomes waist circumference and fat mass, and
rs3790438 and rs3790437 showed an additional interaction with sex
for the outcome BMI. If stratified by sex (supporting Table S9), all
three SNPs show an increased risk for overweight-related outcomes
for the minor alleles in men, and a decreased risk in women.
No SNP was associated in linear regressions with the outcome
leptin levels. SNP rs7531110 showed an interaction with sex
(supporting Tables S8 and S9).
Discussion
Overall results
In the present systematic review we analysed data on the
association between three LEPR gene variants Q223R, K109R,
K656N and overweight-related outcomes. In addition, we
analysed primary data on the association of 15 LEPR tag SNPs
with different overweight-related outcomes from a large, popula-
tion based cross-sectional study. Overall, the meta-analysis of allele
frequencies in obese cases and lean controls did not show an
association between the three SNPs and overweight. In the present
review, we also analysed genotype data, according to different
genetic modes of action (co-dominant, dominant, recessive) and
this did not reveal any clear pattern of association for any of the
tested models. These results support previous findings [14,15].
Studies published after our systematic review also confirm the
unclear association between LEPR and overweight-related out-
comes. Several studies reported no association between Q223R
and overweight [34–36], while one study reported a protective
effect of 223R for overweight in Pacific Islanders [37]. One study
reported an increased risk of 109R for overweight in Asian
children [38]. None of these studies would change our overall
results. Most published studies are underpowered to detect small
effect sizes. However, even in the large CoLaus study, we did not
find evidence for an overall association between LEPR SNPs and
overweight-related outcomes. Our search strategy is likely to have
missed papers that included results on the association between the
selected LEPR variants and obesity but have not mentioned LEPR
in title or abstract. As these studies are likely to be negative, they
would probably not change our overall conclusions.
Implications of findings on interactions and non-coding
variants
Stratification by factors that were reported in the literature as
significant effect modifiers, like ethnicity [39] or study population
[40] (general population versus specified populations) did not
change the results. Interestingly, a stratification by BMI cut-off
value [41] reduced the heterogeneity for Q223R within each of
the two subgroups to non-significant levels. In the stratum with a
cut-off value of BMI= 25, the result showed an increased risk for
overweight for the derived allele. Okorodudu and colleagues [41]
showed that a cutoff value of BMI= 25 had a sensitivity of 0.50
(CI: 0.43–0.57) and a specificity of 0.90 (0.86–0.94) in their study
sample to detect high adiposity. A cutoff value of BMI= 30 had a
sensitivity of 0.42 (0.31–0.43) and a specificity of 0.97 (0.96–0.97).
The fact that stratification by ethnicity did not explain overall
heterogeneity and did not show a significant difference in the
Figure 3. Derived allele frequencies for Q223R, K109R and K656N, by ethnic group. 95% confidence intervals are shown for each derived
frequency.
doi:10.1371/journal.pone.0026157.g003
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association between SNPs and overweight in the different ethnic
groups is surprising, especially if one considers the allele frequency
differences across ethnic groups. The present review supports
previous findings of much higher derived allele frequencies in
Asians for the SNPs Q223R and K109R [15,42]. These higher
derived allele frequencies are compatible with evidence for a
recent positive natural selection of LEPR in Asian populations
[43]. Interestingly, the Taiwanese aborigine population [30] shows
a different picture. The derived allele of Q223R does not only
show a lower frequency like in the Caucasian population, but even
an extremely low frequency, compatible with a selection of the
ancestral allele. This result could be explained by the fact that
Taiwanese aborigines have a different evolutionary history
compared to the other Asian populations included in the present
review (Taiwanese aborigines separated before the selection of the
LEPR variants in continental Asia occurred) [44–46].
Considering major sex differences in leptin levels and fat
distribution, a further potential effect modifier is sex [47,48]. We
could not perform stratification by sex in our meta-analysis as most
studies did not report associations separately in men and women.
One study reported stratified allelic results for the outcome waist
circumference [31], showing an increased risk for large waist
circumference for 223R in men but not in women. Another study
reported an association of K109R with overweight in women [33].
In our linear regressions of the CoLaus data SNPs rs10128072,
rs3790438 and rs3790437 (tag of K656N) showed an interaction
with sex in their association with waist circumference and fat mass.
Sex can therefore be considered as a potential effect modifier for
associations between LEPR SNPs and overweight-related out-
comes. Two studies on the association between Q223R and
overweight published after our systematic review confirm this
view. One study reports an increased risk for 223R for high BMI
in Caucasian girls but not in boys [49]. The other study reports a
protective effect of 223R in Caucasian men but not in women
[50]. These results suggest that stratification by sex should be
recommended for future association studies.The three SNPs of the
CoLaus data showing a significant interaction with sex are all non-
coding variants of the LEPR gene, as is often the case for genetic
associations using high-throughput DNA chips. This may indicate
that these variants tag functional variants located within coding
regions or functional variants located within non-coding regions
influencing gene expression or splicing sites (promoter, introns,
etc). It is more and more recognized that non-coding variants may
impact on disease [51]. A better knowledge of the exact
mechanisms of gene regulation will be crucial to understand the
general role of non-coding DNA in human phenotypic variation.
Evolutionary considerations
In our allele frequency data of Q223R we observed a north-
south gradient in European Caucasians, with higher derived allele
Figure 4. Forest plot on the association between SNP alleles
and overweight in case-control studies by ethnicity. Figure 4a:
Forest plot on the association between Q223R alleles and overweight in
case-control studies by ethnicity. Overall association from random
effects meta-analysis (odds ratio and 95% confidence intervals) and
stratification by ethnic groups are shown, as well as heterogeneity by
means of I2 value for overall measure and for subgroups. Figure 4b:
Forest plot on the association between K109R alleles and overweight in
case-control studies by ethnicity. Overall association from random
effects meta-analysis (odds ratio and 95% confidence intervals) and
stratification by ethnic groups are shown, as well as heterogeneity by
means of I2 value for overall measure and for subgroups. Data from the
CoLaus study are included for the Caucasian population, stratified by
sex. Figure 4c: Forest plot on the association between K656N alleles and
overweight in case-control studies by ethnicity. Overall association from
random effects meta-analysis (odds ratio and 95% confidence intervals)
and stratification by ethnic groups are shown, as well as heterogeneity
by means of I2 value for overall measure and for subgroups.
doi:10.1371/journal.pone.0026157.g004
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Figure 5. Forest plot on the association between Q223R alleles and overweight in case-control studies by potential effect modifier.
Figure 5a: Forest plot on the association between Q223R alleles and overweight in case-control studies by type of population. Overall association
from random effects meta-analysis (odds ratio and 95% confidence intervals) and stratification by type of population are shown, as well as
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frequencies in the north and lower frequencies in the south. The
same phenomenon for SNPs of other genes was reported in the
Framingham Heart Study [52] and in a Europe wide analysis [26].
This phenomenon can be explained by the first settlement of
Europe in Neolithic times from south to north [53]. It can lead to
population stratification, a well known problem in large-scale
association studies which can lead to false positive associations
[39]. Furthermore, population stratification is a major issue in the
interpretation of data from populations of known mixed ancestry,
like Brazilians, Mexicans and certain US populations. For this
reason, we considered such mixed populations separately in our
systematic review and meta-analysis.
An alternative explanation for variation in allele frequency to
the ancient migration hypothesis is positive natural selection. In
fact, evidence for recent positive selection of variants in
polymorphic genes was found in the major ethnic groups
worldwide [43]. It was found that in selected genetic regions
there is a significant over-representation of genetic association with
complex diseases, a fact demonstrating that the understanding of
recent genetic positive selection is important to comprehend the
evolution of human disease [54]. Interestingly, the three LEPR
SNPs Q223R, K109R and K656N show signals for positive
selection in the Asian population [43]. This finding is compatible
with the much higher derived allele frequencies for Q223R and
K109R and the much lower derived allele frequency for K656N in
Asians in our systematic review. It seems that the sequence
changes were of advantage (or disadvantage) for Asian populations
6’000–8’000 years ago, a time that corresponds to the introduction
of agriculture in Asia [55,56]. It was therefore speculated that the
LEPR gene could be considered a ‘‘thrifty’’ gene, leading to an
accumulation of fat tissue in times of plenty, providing a reserve
for times of hunger [57,58]. As an alternative explanation for the
positive selection of LEPR in Asian populations [59], Hancock
et al. found associations of several LEPR variants (among them
K109R) with climate variables suggesting a role of climate
adaptations in the biological processes underlying cold adaptation
and overweight. They suggest that variants like K109R might be
deleterious in hot equatorial climates and advantageous in colder
climates.
The influence of positive selection and the selective pressures
operating in the past are issues of major importance that need
further investigation. The human fat distribution, especially the
subcutaneous fat, is unique among primates and among most land
mammals. While primates have on average 5% body fat, a normal
weight human male has approximately 10–15% body fat and a
normal weight human female 20–25% [60]. Humans are born
with a substantial layer of subcutaneous fat, showing the
independence of this feature from diet at least in the first phase
of life. The human subcutaneous fat and the susceptibility to
obesity can therefore not only be explained by a disbalance
Table 4. Association from logistic regression models between LEPR variants and overweight in the CoLaus study.
SNP
Allele minor/
major
OR (95% CI)
heterozygote
OR (95% CI)
homozygote minor
P
(chi2, 2df)
OR (95% CI)
additive
P add
(1df)
P interaction
SNP*sex
rs10128072 G/T 1.02 (0.9–1.16) 1.01 (0.71–1.44) 0.96 1.01 (0.91–1.13) 0.79 0.07
rs7518849 G/A 1.01 (0.85–1.20) 1.25 (0.43–3.69) 0.91 1.02 (0.87–1.20) 0.81 0.99
rs970467 T/C 0.91 (0.79–1.05) 0.72 (0.42–1.21) 0.21 0.90 (0.79–1.02) 0.09 0.58
rs10889553 T/C 1.14 (0.94–1.38) 2.72 (0.48–15.51) 0.21 1.16 (0.96–1.40) 0.12 0.21
rs10889567* C/T 1.07 (0.94–1.22) 1.17 (0.99–1.38) 0.19 1.08 (0.99–1.17) 0.07 0.23
rs1137100** G/A 1.05 (0.92–1.19) 1.14 (0.89–1.46) 0.51 1.06 (0.96–1.16) 0.26 0.86
rs3790438 A/T 0.87 (0.76–0.99) 0.94 (0.68–1.31) 0.10 0.90 (0.81–1.01) 0.07 0.08
rs9436746 A/C 1.11 (0.98–1.26) 1.29 (1.09–1.53) 0.01 1.13 (1.04–1.23) 0.003 0.25
rs2025805 A/G 0.82 (0.71–0.93) 0.87 (0.74–1.02) 0.01 0.93 (0.86–1.00) 0.06 0.35
rs1805096 T/C 1.01 (0.90–1.14) 0.88 (0.74–1.04) 0.22 0.95 (0.88–1.03) 0.25 0.51
rs9436748 T/G 0.84 (0.74–0.97) 0.94 (0.79–1.11) 0.04 0.95 (0.88–1.04) 0.25 0.14
rs7531110 G/T 1.04 (0.93–1.18) 1.18 (0.99–1.40) 0.18 1.08 (0.99–1.17) 0.08 0.16
rs10158279 C/A 1.01 (0.89–1.16) 1.13 (0.96–1.33) 0.25 1.06 (0.98–1.15) 0.15 0.41
rs11585329 A/C 1.05 (0.93–1.20) 0.88 (0.62–1.26) 0.53 1.02 (0.91–1.13) 0.78 0.57
rs3790437*** C/T 0.92 (0.81–1.04) 0.93 (0.70–1.25) 0.37 0.94 (0.85–1.03) 0.20 0.07
Results are odds ratios (95% confidence intervals) from logistic regression models (general model and additive model) including age, sex, alcohol consumption,
smoking, and the first and second principal components, as covariates. In addition, the result of the interaction with sex is given. Statistically significant results are
shown in bold.
*tag of Q223R.
**K109R.
***tag of K656N.
doi:10.1371/journal.pone.0026157.t004
heterogeneity by means of I2 value for overall measure and for subgroups. Specified populations are all populations not declared as general
populations in the original studies. Figure 5b: Forest plot on the association between Q223R alleles and overweight in case-control studies by BMI
cut-off value. Overall association from random effects meta-analysis (odds ratio and 95% confidence intervals) and stratification by BMI cut-off value
are shown, as well as heterogeneity by means of I2 value for overall measure and for subgroups. For definition of BMI cut-off values see main text.
doi:10.1371/journal.pone.0026157.g005
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between energy intake and expenditure, but also demands an
evolutionary explanation.
Conclusions
In conclusion, our systematic review did not show an overall
association between the LEPR SNPs Q223R, K109R and K656N
and obesity-related outcomes, but Q223R showed a significant
association with overweight in studies considering a BMI cut-off
value of 25 to separate normal weight from overweight. In our
analyses of primary data from the CoLaus study, rs9436746 was
associated with overweight and rs10889553 with waist circumfer-
ence. Our stratified analyses in CoLaus data suggest that sex could
potentially modify the association of LEPR variants with obesity-
related phenotypes, which is not surprising considering the major
differences in both leptin levels and fat distribution between the
sexes. Genetic association studies on obesity traits should consider
sex as a potential effect modifier. Finally, the role of natural
selection in allele frequency differences and the potential impact of
selection on gene-phenotype associations also need further
investigation.
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Table 5. Association from logistic regression models between LEPR variants and waist circumference in the CoLaus study.
SNP
Allele minor/
major
OR (95% CI)
heterozygote
OR (95% CI)
homozygote minor
P
(chi2, 2df)
OR (95% CI)
additive
P add
(1df)
P interaction
SNP*sex
rs10128072 G/T 1.11 (0.97–1.28) 1.08 (0.74–1.58) 0.31 1.09 (0.97–1.23) 0.14 0.06
rs7518849 G/A 1.04 (0.87–1.25) 1.99 (0.70–5.66) 0.40 1.08 (0.91–1.29) 0.37 0.51
rs970467 T/C 0.98 (0.84–1.14) 0.53 (0.28–1.03) 0.14 0.93 (0.81–1.07) 0.32 0.56
rs10889553 T/C 1.19 (0.97–1.45) 1.94 (0.36–10.58) 0.18 1.20 (0.99–1.46) 0.06 0.08
rs10889567* C/T 1.07 (0.93–1.23) 1.02 (0.85–1.22) 0.61 1.02 (0.93–1.11) 0.65 0.30
rs1137100** G/A 1.01 (0.88–1.16) 0.93 (0.71–1.22) 0.85 0.99 (0.90–1.10) 0.91 0.25
rs3790438 A/T 0.90 (0.78–1.04) 0.90 (0.63–1.30) 0.32 0.92 (0.82–1.03) 0.16 0.16
rs9436746 A/C 1.05 (0.92–1.20 1.19 (0.99–1.42 0.17 1.09 (1.00–1.18) 0.06 0.29
rs2025805 A/G 0.87 (0.76–1.09) 0.92 (0.78–1.09) 0.18 0.95 (0.87–1.03) 0.22 0.22
rs1805096 T/C 1.02 (0.90–1.16) 0.84 (0.70–1.02) 0.12 0.95 (0.87–1.03) 0.21 0.53
rs9436748 T/G 0.85 (0.74–0.98) 0.95 (0.79–1.13) 0.07 0.95 (0.87–1.04) 0.24 0.34
rs7531110 G/T 1.00 (0.88–1.14) 1.03 (0.86–1.24) 0.94 1.02 (0.93–1.11) 0.71 0.06
rs10158279 C/A 1.05 (0.91–1.21) 1.04 (0.87–1.23) 0.82 1.02 (0.94–1.11) 0.63 0.17
rs11585329 A/C 1.06 (0.92–1.21) 0.96 (0.65–1.41) 0.68 1.03 (0.92–1.16) 0.59 0.58
rs3790437*** C/T 0.91 (0.80–1.04) 0.96 (0.70–1.31) 0.37 0.94 (0.84–1.05) 0.25 0.06
Results are odds ratios (95% confidence intervals) from logistic regression models (general model and additive model) including age, sex, height, alcohol consumption,
smoking, and the first and second principal components, as covariates. In addition, the result of the interaction with sex is given. Statistically significant results are
shown in bold.
*tag of Q223R.
**K109R.
***tag of K656N.
doi:10.1371/journal.pone.0026157.t005
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